Sun Pharmaceutical Industries has received its board’s approval to raise up to Rs 8,000 crore. The company will raise the said fund through domestic or international offerings.
Sun Pharma is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.